Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-specific physical partitioning refers to the passive, physical distribution of molecules—such as drugs, metabolites, or endogenous components—across cellular, subcellular, or supramolecular environments, dictated by their physicochemical properties (e.g., hydrophobicity, solubility, charge) rather than selective biological recognition. This process underlies phenomena such as membrane partitioning, accumulation in lipid droplets or biomolecular condensates, and phase separation, and can significantly alter local concentration and, thus, biological effect. Non-specific partitioning does not involve specific molecular targets such as receptors or enzymes, but is a physical effect that impacts the context in which drugs and other molecules may act. Biologically, partitioning influences drug distribution, subcellular localization, and residence times, but does so through physical chemistry, not discrete molecular recognition. In drug discovery or pharmacology, the term may be used to denote drug accumulation in compartments like lipid rafts, membranes, or phase-separated domains, which can indirectly affect efficacy and safety by changing local concentrations. There is no gene, protein, or standard abbreviation. This is not a target for structure-based drug design, nor does it have disease-modifying roles per se, though it may modify pharmacodynamics by changing exposure. It is important not to confuse "non-specific physical partitioning" with canonical drug targets such as enzymes, receptors, ion channels, or transporters. It is rather a contextual property relevant in pharmacokinetics and cell biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific physical partitioning.